Platelet Counts During Pregnancy as Predictor of Subsequent Myeloproliferative Neoplasm
European Journal of Haematology · 2026
DOI: 10.1111/ejh.70257 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Freja Rueholm Klok und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. Hauptthemen laut MEDLINE: Myeloproliferative Disorders, Pregnancy Complications, Neoplastic. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Aase og Ejnar Danielsens Fond.
Abstract (Originalsprache)
Objectives
Myeloproliferative neoplasms (MPNs) are associated with increased thrombosis risk, and earlier identification is essential to reduce preventable complications. We investigated whether platelet counts during pregnancy were higher in women diagnosed with MPN after pregnancy than in controls.
Methods
We conducted a nested case–control study of pregnant women in two Danish regions between 2010 and 2017 using registry and laboratory data. The primary exposure was platelet counts during pregnancy, and the primary outcome was a subsequent MPN diagnosis.
Results
We included 49 cases with subsequent MPN, and 979 matched controls. Cases had significantly higher platelet counts (×10 9 /L) during pregnancy (325 (IQR 199–419) vs. 219 (IQR 183–254), p = 0.002), and platelet counts > 400 occurred in 29% of cases versus 2% of controls ( p < 0.001). Adjusted models showed an estimated 85 higher platelet count in cases, and platelet counts > 400 during pregnancy were associated with an 18‐fold increased odds ratio (95% CI: 6–61) for later MPN. MPN status was strongly associated with higher platelet counts before, during, and after pregnancy.
Conclusion
Elevated platelet counts during pregnancy are strongly associated with subsequent MPN, suggesting that routine prenatal platelet counts may enable early identification of women at risk of MPN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
- Department of Obstetrics and Gynecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
- Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
- Department of Clinical Biochemistry, Zealand University Hospital, Køge, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Fetal Medicine Unit, Department of Obstetrics and Gynecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
ORCID-Profile: Freja Rueholm Klok
Förderung
- Aase og Ejnar Danielsens Fond
Zitieren
APA
Klok, F. R., Jørgensen, K. J., Larsen, M. K., Dahl, M., Jørgensen, F. S., Skov, V., Kjær, L., Ellervik, C., Jørgensen, H. L., & Hasselbalch, H. C. (2026). Platelet Counts During Pregnancy as Predictor of Subsequent Myeloproliferative Neoplasm. European Journal of Haematology. https://doi.org/10.1111/ejh.70257
Vancouver
Klok FR, Jørgensen KJ, Larsen MK, Dahl M, Jørgensen FS, Skov V, et al. Platelet Counts During Pregnancy as Predictor of Subsequent Myeloproliferative Neoplasm. European Journal of Haematology. 2026. doi:10.1111/ejh.70257
BibTeX
@article{Klok2026,
author = {Klok, Freja Rueholm and Jørgensen, Katrine Jeong and Larsen, Morten Kranker and Dahl, Morten and Jørgensen, Finn Stener and Skov, Vibe and Kjær, Lasse and Ellervik, Christina and Jørgensen, Henrik Løvendahl and Hasselbalch, Hans Carl},
title = {Platelet Counts During Pregnancy as Predictor of Subsequent Myeloproliferative Neoplasm},
journal = {European Journal of Haematology},
year = {2026},
doi = {10.1111/ejh.70257}
}
EUVIMED